approval · primary record
CABOZANTINIB LAURYLSULFATE
FDA · NDA · 2026-09-03
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2026-09-03 |
| Brand | OMCAZIO |
| Sponsor | HANDA ONCOL |
| Route | ORAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:42.261Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:CABOZANTINIB LAURYLSULFATE:2026-09-03
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.